Trial intelligence / Profile preview

Ondansetron + dexamethasone versus metoclopramide + dexamethasone for prevention of spinal anesthesia complications in cesarean section

IRCT20210403050823N1Phase 3Completed

Sponsor
Khalkhal University of Medical Sciences
Start
Apr 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ondansetron, dexamethasone and metoclopramide in spinal anesthesia complication, postoperative nausea and vomiting (PONV), hypotension and 1 more (3 arms), sponsored by Khalkhal University of Medical Sciences. Primary endpoints: Reduction in nausea and vomiting, Reduction in shivering and 2 more. Started Apr 2021; status: completed.

02

Drugs

ondansetrondexamethasonemetoclopramide
03

Conditions

spinal anesthesia complicationpostoperative nausea and vomiting (PONV)hypotensionpost-dural puncture headache (PDPH)

Beyond the preview

Go deeper on IRCT20210403050823N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210403050823N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call